rituximab - Robuta Search

https://adisinsight.springer.com/drugsafety/803591938?error=cookies_not_supported&code=eaf5c37a-df0b-46af-8b2d-1f04a7bf0067 Rituximab - AdisInsight A 32-year-old woman developed reactivation of SARS-CoV-2 infection following administration of rituximab for highly active multiple sclerosis [route and dose rituximab adisinsight https://refubium.fu-berlin.de/handle/fub188/26522 Refubium - Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-lenalidomide-and-rituximab-with-or-without-bendamustine-for-follicular-lymphoma-rebel A trial of lenalidomide and rituximab with or without bendamustine for follicular lymphoma (ReBEL) This trial is for people with a type of non Hodgkin lymphoma called follicular lymphoma that has come back after treatment (relapsed). https://doctor.ndtv.com/faq/are-rituximab-and-bendamustine-effective-for-treating-chronic-lymphocytic-leukaemia-31219 Are rituximab and bendamustine effective for treating chronic lymphocytic leukaemia? rituximab bendamustine effective treating chronic https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-00035&r=1 Enasidenib with or without Rituximab for the Treatment of Relapsed and Refractory IDH2-Mutant... Enasidenib with or without Rituximab for the Treatment of Relapsed and Refractory IDH2-Mutant Angioimmunoblastic T-cell Lymphoma https://adisinsight.springer.com/drugsafety/803760959?error=cookies_not_supported&code=1ec499e5-9e5d-4aa1-a36c-469aead75ca4 Rituximab - AdisInsight A 53-year-old man received off-label treatment with rituximab for multifocal motor neuropathy.The man was diagnosed with multifocal motor neuropathy at the age rituximab adisinsight https://adisinsight.springer.com/drugsafety/803017607?error=cookies_not_supported&code=07dd2630-56bf-44ec-a528-9e8c77997b55 Rituximab - AdisInsight A 45-year-old man developed acute, severe aortic incompetence following rituximab therapy for relapsing polychondritis.The man, who had been diagnosed with rituximab adisinsight https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-ibrutinib-with-chemotherapy-and-rituximab-for-a-type-of-dlbcl-phoenix A trial of ibrutinib with chemotherapy and rituximab for a type of diffuse large B cell lymphoma... This trial is looking at a drug called ibrutinib for a type of non Hodgkin lymphoma called diffuse large B cell lymphoma (DLBCL). https://adisinsight.springer.com/drugsafety/803392264?error=cookies_not_supported&code=d3d88a5d-5fd8-427e-a3c2-27e791ff152f Carfilzomib/dexamethasone/rituximab - AdisInsight In a retrospective, single centre study of 60 patients treated from 1 April 2014 to 30 November 2016, 6 patients [ages and sexes not stated] were described, of carfilzomib dexamethasone rituximab adisinsight https://adisinsight.springer.com/drugsafety/803924417?error=cookies_not_supported&code=94d7367d-4daf-42b6-bcb5-c856092773d8 Rituximab - AdisInsight Two patients with systemic sclerosis developed acute thrombocytopenia following treatment with rituximab. Both patients experienced severe thrombocytopenia rituximab adisinsight https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/2296/ "Rituximab for the treatment of relapsing/refractory thrombotic thrombo" by A. Ahmad, A. Aggarwal... By A. Ahmad, A. Aggarwal, D. Sharma, et al., Published on 01/01/02 https://adisinsight.springer.com/drugsafety/803266363?error=cookies_not_supported&code=8cf4d299-0d5e-43a3-be5c-1e29591fe8b6 Rituximab - AdisInsight An 81-year-old man developed cytokine storm and shock following treatment with rituximab [dosage and route not stated].The man, who had been diagnosed with ANCA rituximab adisinsight https://adisinsight.springer.com/drugsafety/803297816?error=cookies_not_supported&code=bb6e653d-1103-4e63-bd6e-b66d26965076 Abatacept/rituximab - AdisInsight In a retrospective cohort study of 38 patients, 10 patients [ages and sexes not stated] were described, who had graft failure (eight patients), BK abatacept rituximab adisinsight https://adisinsight.springer.com/trials/700392636?error=cookies_not_supported&code=4d31c9e0-961e-411c-997e-c9e7883c08ba A Phase II, Multicenter, Single-Arm Study of Sonrotoclax, Zanubrutinib and Rituximab in Previously... Follicular lymphoma (FL) remains an incurable indolent B-cell lymphoma for many patients, and although rituximab-based chemoimmunotherapy can achieve high https://op.europa.eu/en/web/public-procurement/procurement-details/-/procurement/c061dfff-2f05-4559-b477-13078d2e2da9 SUPPLY OF RITUXIMAB EXCLUSIVE MEDICINAL PRODUCTS (MABTHERA 1400 MG INY SC C/1) OF ROCHE FARMA, FOR... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-02851&r=1 Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment... Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's... https://research.monash.edu/en/publications/outcomes-for-transformed-follicular-lymphoma-in-the-rituximab-era/ Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience... follicular lymphoma in the https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-04108&r=1 Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients with... Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients with Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial https://adisinsight.springer.com/drugsafety/803861476?error=cookies_not_supported&code=3d29f844-0584-4409-bd3d-1f56aad270f2 Recombinant-factor-VIIa/rituximab - AdisInsight A 63-year-old man exhibited a lack of efficacy during treatment with recombinant-factor-VIIa and rituximab for acquired coagulopathy due to combined factor VIII recombinant factor viia rituximab adisinsight https://adisinsight.springer.com/drugsafety/803371270?error=cookies_not_supported&code=308378c7-fcda-476b-871b-73fe97305ff2 Rituximab - AdisInsight In a retrospective study of patient records between January 2011 and January 2018, a patient [age and sex not stated] was described, who experienced rituximab adisinsight https://adisinsight.springer.com/drugsafety/803724484?error=cookies_not_supported&code=a03a125f-105c-4b0a-97b8-9dfae7ea46e6 Rituximab - AdisInsight In a single-center retrospective study of 24 children with relapsing (FR) or steroid-dependent nephrotic syndrome (SDNS) conducted between December 2017 and rituximab adisinsight https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-brentuximab-vedotin-lenalidomide-and-rituximab-relapsed-or-refractory-large-b-cell FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large... On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with... https://adisinsight.springer.com/trials/700052705?error=cookies_not_supported&code=eed59823-a646-4a12-82ea-7a7e3c6508a7 Phase I/II Trial of Maintenance Therapy With Lenalidomide and Rituximab Following High-Dose... This trial will investigate the tolerability and efficacy of lenalidomide [Revlimid; CC-5013; IMiD-1] when given together with rituximab [Rituxan; Mabthera; https://adisinsight.springer.com/drugsafety/803435360?error=cookies_not_supported&code=fe84d3af-03c6-4bb6-8d89-a22b7215cdee Rituximab - AdisInsight In a study of 10 patients, a 38-year-old woman was described, who developed severe fatigue, after receiving rituximab for pemphigus vulgaris. The woman received rituximab adisinsight https://adisinsight.springer.com/drugsafety/803511830?error=cookies_not_supported&code=fdbf644c-4532-4de9-b028-ef8102698e9f Rituximab - AdisInsight An approximately 66-year-old woman developed unspecified neurological side effects during treatment with rituximab*.The woman, who had hypertension and rituximab adisinsight https://adisinsight.springer.com/drugsafety/803865049?error=cookies_not_supported&code=688a2082-0a6e-4751-bc5e-f049918eed98 Immune-globulin/rituximab - AdisInsight In a case series, an 18-year-old man and 8-year-old boy were described, who exhibited lack of efficacy during treatment with immune-globulin or rituximab for immune globulin rituximab adisinsight https://openresearch.surrey.ac.uk/esploro/outputs/journalArticle/Can-rituximab-induce-long-term-disease-remission/99513515402346 Can rituximab induce long-term disease remission in patients with intra-ocular non-infectious... Sep 1, 2013 - Treatment of non-infectious uveitis is based primarily on the use of systemic corticosteroids and second-line immunosuppressive drugs. However, their extensive... https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1533/ J9311 Rituximab and Hyaluronidase - CanMED: HCPCS CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. rituximab hyaluronidase hcpcs https://epub.ub.uni-muenchen.de/126345/ Outcome of rituximab treatment in children with non-dialysis-dependent anti-GBM disease https://adisinsight.springer.com/drugsafety/803902925?error=cookies_not_supported&code=629be7ce-5fd7-4dc5-838d-c72fad2b9b4a Mycophenolate-mofetil/rituximab - AdisInsight In a retrospective cohort study of 11 patients conducted between 2016 and 2025, 2 patients (1 man and 1 woman) aged 56 and 61 years were described, of whom one mycophenolate mofetil rituximab adisinsight https://pure.psu.edu/en/publications/combined-rituximab-and-plasmapheresis-or-plasma-exchange-for-foca/ Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in... https://experts.mcmaster.ca/scholarly-works/1110019 A Randomized Trial Of Rituximab Vs Observation... Learn about the scholarly work entitled A Randomized Trial Of Rituximab Vs Observation... randomized trial rituximab vs observation https://pubmed.ncbi.nlm.nih.gov/37290967/ Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder This study provides Class IV evidence that de-escalation of rituximab increases the probability of disease reactivation. in patients neuromyelitis optica rituximab de escalation https://adisinsight.springer.com/drugsafety/803429897?error=cookies_not_supported&code=5f8e36fc-65be-42c5-9ce6-6c09c00770f9 Oxaliplatin/rituximab - AdisInsight In a case series, a 58-year-old man and 78-year-old man developed hypersensitivity reaction during chemotherapy with oxaliplatin and rituximab, respectively oxaliplatin rituximab adisinsight https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-lenalidomide-with-rituximab-for-low-grade-non-hodgkin-lymphoma-augment Cancer Research UK | A trial of lenalidomide and rituximab for follicular lymphoma or marginal zone... This trial looked at adding lenalidomide to rituximab for follicular lymphoma or marginal zone lymphoma. https://adisinsight.springer.com/trials/700298681?error=cookies_not_supported&code=7b4a2a3e-a3c4-42ab-9fc1-05da17c0986b Efficacy of First Line Bortezomib, Rituximab, Ibrutinib (B-RI) for Patients With Treatment Naive... The aim of this study is to investigate the efficacy and toxicity of the chemotherapy-free combination Bortezomib, Rituximab, Ibrutinib (B-RI) in treatment https://open.library.emory.edu/concern/publications/6cfa92db-2f7f-4434-9ad6-699f3c1e19cd The Use and Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma Diagnosed... The Use and Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma Diagnosed Between 2004 and 2007 in the United States https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-ro5072759-rituximab-for-chronic-lymphocytic-leukaemia A trial looking at obinutuzumab and rituximab for chronic lymphocytic leukaemia (CLL) This trial looked at which treatment is better to help people with CLL who tested positive to the protein CD20 and who have other health problems. chronic lymphocytic leukaemia looking at https://adisinsight.springer.com/drugsafety/803577045?error=cookies_not_supported&code=9518afc8-7da1-4123-b963-624d371a02ea Immune-globulin/prednisone/rituximab - AdisInsight In a retrospective single-center, cohort study involving 117 patients with pemphigus treated at a tertiary referral center in Israel between 01 January 1995 and immune globulin prednisone rituximab adisinsight https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1100077/full Frontiers | 99mTc-rituximab tracer injection for guiding internal mammary sentinel lymph nodes... Objective: To explore the use of 99mTc-rituximab tracer injection for internal mammary sentinel lymph node (IM-SLN) detection in patients with primary breast... https://adisinsight.springer.com/drugsafety/803836028?error=cookies_not_supported&code=d3729c1f-246e-4d70-a9bc-0c2268c50701 Prednisolone/rituximab - AdisInsight A retrospective study was conducted in Singapore between 2015 and 2019 on 12 patients with pemphigus, who previously treated with prednisolone, received prednisolone rituximab adisinsight https://adisinsight.springer.com/drugsafety/803747448?error=cookies_not_supported&code=99da21a7-8262-4e3b-a2cb-82eb2fe1ffdd Corticosteroids/rituximab - AdisInsight An 80-year-old woman developed Kaposi's sarcoma during treatment with rituximab and unspecified corticosteroids for thrombocytopenia [routes not stated; not all corticosteroids rituximab adisinsight https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39297 LCD - Off-label Use of Rituximab and Rituximab Biosimilars (L39297) Use this page to view details for the Local Coverage Determination for Off-label Use of Rituximab and Rituximab Biosimilars. off label lcd use rituximab biosimilars https://www.cirm.ca.gov/cirm-trial/fludarabine-and-cyclophosphamide-with-or-without-rituximab-before-cd19-chimeric-antigen-receptor-t-cells-for-the-treatment-of-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-2/ Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T... https://pubmed.ncbi.nlm.nih.gov/34387760/ Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective... Rituximab is shown to be effective in treating myositis along with corticosteroids as well as a corticosteroid-sparing agent in retrospective studies and... as a agent in rituximab glucocorticoid sparing https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=59101&ver=20& Article - Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars (A59101) Use this page to view details for the Local Coverage Article for Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars. billing and coding off label article https://pubmed.ncbi.nlm.nih.gov/26492934/ Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in... Accurate identification of patients likely to achieve long-progression-free survival (PFS) after chemoimmunotherapy is essential given the availability of less... https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2019.00313/full Frontiers | Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on... Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment for steroid-sensitive nephrotic syndrome (SSNS) and steroid... https://pubmed.ncbi.nlm.nih.gov/33591038/ Rituximab as an Adjuvant Rescue Treatment for Ocular Cicatricial Pemphigoid The consideration of rituximab earlier in treatment of OCP as a rescue and/or maintenance therapy could result in an earlier arrest of disease progression,... treatment for rituximab adjuvant rescue ocular https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-04984&r=1 A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R)... A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With... https://pubmed.ncbi.nlm.nih.gov/17395584/ Structural basis for recognition of CD20 by therapeutic antibody Rituximab Rituximab is a widely used monoclonal antibody drug for treating certain lymphomas and autoimmune diseases. To understand the molecular mechanism of... by therapeutic structural basis recognition antibody https://www.nice.org.uk/guidance/ta195 Overview | Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of... Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), rituximab (MabThera) and abatacept (Orencia). These drugs... for the overview adalimumab etanercept infliximab https://open.library.emory.edu/concern/publications/5e5118dc-ea0a-478f-b9b6-55c8ccda4f6d A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental... A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol... randomized controlled trial https://boris-portal.unibe.ch/entities/publication/0503350d-c542-45b2-8a0e-1617626ea706 Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants. INTRODUCTION In breastfeeding patients with chronic inflammatory rheumatic diseases, a postpartum flare may require the use of biologics. However, data on the... https://adisinsight.springer.com/drugsafety/803873755?error=cookies_not_supported&code=4751a6f0-8cf3-4f1b-a1c5-f6cb6949ded5 Nivolumab/rituximab/steroids - AdisInsight A 49-year-old woman exhibited lack of efficacy during treatment with rituximab for Epstein-Barr viraemia; unspecified steroids and nivolumab for haemophagocytic nivolumab rituximab steroids adisinsight https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=58582&ver=17 Article - Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars (A58582) Use this page to view details for the Local Coverage Article for Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars. billing and coding off label article https://adisinsight.springer.com/drugsafety/803775235?error=cookies_not_supported&code=ca214683-6bda-4f4b-9a40-090021287e24 Obinutuzumab/rituximab - AdisInsight In a report, a 55-year-old woman and a 73-year-old woman experienced prolonged SARS-CoV-2 infection during treatment with obinutuzumab and rituximab, obinutuzumab rituximab adisinsight https://adisinsight.springer.com/drugsafety/803878875?error=cookies_not_supported&code=bc9170b9-baea-42f0-87de-5c2a93ea3902 Rituximab/Immune-globulin - AdisInsight In a single center retrospective study involving 48 patients, who developed COVID-19 infection while receiving rituximab between 25 May 2023 to 3 January 2024, immune globulin rituximab adisinsight https://experts.umn.edu/en/publications/phase-i-trial-of-rituximab-cladribine-and-temsirolimus-rct-for-in/ Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell... https://pubmed.ncbi.nlm.nih.gov/19847908/ Rituximab in patients with primary progressive multiple sclerosis: results of a randomized... Although time to CDP between groups was not significant, overall subgroup analyses suggest selective B-cell depletion may affect disease progression in younger... in patients https://www.news-medical.net/news/2009/03/11/46787.aspx Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint Jun 20, 2019 - Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients... lupus nephritis study rituxan rituximab misses https://pubmed.ncbi.nlm.nih.gov/35841908/ Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting... Swedish Research Council. safety and efficacy https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rituximab Definition of rituximab - NCI Dictionary of Cancer Terms - NCI NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. definition of rituximab nci dictionary cancer https://experts.umn.edu/en/projects/velcade-and-rituximab-in-the-treatment-of-postransplant/ Velcade and Rituximab in the Treatment of Postransplant - Experts@Minnesota in the velcade rituximab treatment experts https://adisinsight.springer.com/drugsafety/803848022?error=cookies_not_supported&code=925596f0-a8e9-4b0a-b886-ed77c2ae3981 Methotrexate/rituximab/temozolomide - AdisInsight In a retrospective study conducted between 2002 and 2022 involving 124 patients, 3 women aged 22-48 years were described, who exhibited lack of efficacy during methotrexate rituximab temozolomide adisinsight https://adisinsight.springer.com/trials/700391424?error=cookies_not_supported&code=18dec74f-a96d-415e-8ad0-e7ab0d076156 A Single-arm, Non-blind, Single-center Study to Evaluate the Safety and Tolerability of Rituximab... 1. Study population:It is applicable to male participants with genetically confirmed and clinically confirmed Duchenne muscular dystrophy (DMD), aged between 6 https://arxiv.org/abs/2110.01545v1 [2110.01545v1] Mathematical modeling of tumor immune-system interactions: the effect of rituximab... Abstract page for arXiv paper 2110.01545v1: Mathematical modeling of tumor immune-system interactions: the effect of rituximab on breast cancer immune response mathematical modeling https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-adding-rituximab-mitoxantrone-to-fludarabine-cyclophosphamide-treat-chronic-lymphocytic-leukaemia A trial looking at mitoxantrone and low dose rituximab with chemotherapy for chronic lymphocytic... This trial was for people with chronic lymphocytic leukaemia (CLL). It was for people who had not yet had treatment for their disease. https://www.cancer.gov/about-cancer/treatment/drugs/rituximab Rituximab - NCI This page contains brief information about rituximab and a collection of links to more information about the use of this drug, research results, and ongoing... rituximab nci https://pubmed.ncbi.nlm.nih.gov/24591201/ Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL... This randomized, noninferiority (NI), global, phase 3 study evaluated the efficacy and safety of bendamustine plus rituximab (BR) vs a standard... https://revistas.usp.br/bjps/en/article/view/87931 Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma | Brazilian Journal... https://pubmed.ncbi.nlm.nih.gov/32729848/ Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil Lymphocytic hypophysitis is a rare inflammatory disorder of the pituitary gland. In exceptional cases, there is infiltration of the cavernous sinus with... successfully treated rituximab mycophenolate https://research.birmingham.ac.uk/en/publications/short-term-efficacy-and-safety-of-rituximab-therapy-in-refractory/ Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus:... efficacy and safety https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/a-single-arm-phase-iii-study-of-tazemetostat A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the... A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma https://www.qk.sjtu.edu.cn/jimcp/EN/10.16138/j.1673-6087.2025.04.10 A case of neuropsychiatric lupus successfully treated with sequential therapy of rituximab and... Neuropsychiatric lupus erythematosus (NPSLE) is a severe complication ... a case https://pubmed.ncbi.nlm.nih.gov/18572292/ Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone... Lupus nephritis (LN) is a severe and frequent complication of systemic lupus erythematosus. For decades, cyclophosphamide-based regimens have been the gold... lupus nephritis https://researchconnect.buffalo.edu/en/publications/combined-induction-therapy-with-rabbit-antithymocyte-globulin-and/ Combined induction therapy with rabbit antithymocyte globulin and rituximab in highly sensitized... https://www.cancer.gov/research/participate/clinical-trials/intervention/rituximab?pn=1 Clinical Trials Using Rituximab - NCI NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying rituximab. clinical trials using rituximab nci https://pubmed.ncbi.nlm.nih.gov/11807147/?dopt=Abstract CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse... The addition of rituximab to the CHOP regimen increases the complete-response rate and prolongs event-free and overall survival in elderly patients with... chop chemotherapy plus rituximab compared https://www.cochrane.org/zh-hant/evidence/CD009130_use-monoclonal-antibody-rituximab-patients-relapsing-remitting-multiple-sclerosis-rrms The use of the monoclonal antibody rituximab in patients with relapsing remitting multiple... the use monoclonal antibody https://pubmed.ncbi.nlm.nih.gov/41583797/ Rituximab-Induced Remission in Proliferative Glomerulonephritis With Monoclonal Immunoglobulin G... Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) is a rare form of monoclonal gammopathy of renal significance (MGRS). The natural... rituximab induced remission glomerulonephritis monoclonal https://adisinsight.springer.com/drugsafety/803927228?error=cookies_not_supported&code=a75f4af0-eaea-48ab-90e2-a7f80ebbf6e3 Bendamustine/Rituximab - AdisInsight Two patients [ages and sexes not stated] with relapsed or refractory diffuse large B-cell lymphoma received salvage therapy with bendamustine and rituximab bendamustine rituximab adisinsight https://adisinsight.springer.com/drugsafety/803645097?error=cookies_not_supported&code=b9ea9dec-41f9-4c07-a91c-dd3bda51da19 Rituximab - AdisInsight A 67-year-old man developed hepatitis B virus (HBV) reactivation following treatment with rituximab for Ritcher Syndrome.The man with medical history of chronic rituximab adisinsight https://pubmed.ncbi.nlm.nih.gov/41071071/ Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia... RIAT is a frequent complication of RTX induction in patients with AAV, with diabetes mellitus and cardiac disease being strong risk factors. Our predictive... https://adisinsight.springer.com/drugsafety/803085206?error=cookies_not_supported&code=f4a924fe-e00b-4b1e-9436-f617b2d74f42 Rituximab - AdisInsight A 5-year-old boy developed late-onset neutropenia after receiving rituximab for nephrotic syndrome.The boy had received therapies including tacrolimus and rituximab adisinsight https://open.bu.edu/items/8af3bc77-8118-47d9-999e-c4bb84eb99d9 Clinical outcomes in patients with pemphigus vulgaris receiving a combination rituximab and... Pemphigus Vulgaris is a potentially fatal autoimmune blistering disease that affects the skin and mucous membranes. The conventional therapy for this disease... clinical outcomes pemphigus vulgaris https://adisinsight.springer.com/drugsafety/803929786?error=cookies_not_supported&code=a1e7e115-8e2f-4a38-a2c5-8cb474d05759 Inebilizumab/Rituximab - AdisInsight In a multicentre Chinese cohort of 229 patients [age not stated; sex not stated] with aquaporin-4 immunoglobulin G seropositive neuromyelitis optica spectrum inebilizumab rituximab adisinsight https://adisinsight.springer.com/drugsafety/803926353?error=cookies_not_supported&code=1e74af2d-7bc9-4ee2-beec-0a626d5d2adb Lm 101/Rituximab - AdisInsight Adult patients with relapsed or refractory lymphoma received LM-101, either as monotherapy or in combination with rituximab, and experienced grade 3 or higher lm rituximab adisinsight https://adisinsight.springer.com/drugsafety/803357869?error=cookies_not_supported&code=7163d3f4-3a2c-48e1-84c2-6ccbd3606382 Rituximab - AdisInsight A woman in her 60s [exact age at the time of event onset not stated] developed pyoderma gangrenosum (PG) during treatment with rituximab for rheumatoid rituximab adisinsight https://adisinsight.springer.com/drugsafety/803744490?error=cookies_not_supported&code=82e34f89-958a-4d27-aa27-e723b9e249e4 Rituximab - AdisInsight A man in his early 40s [exact age not stated] exhibited no response during treatment with prescribed underdoses of rituximab for pure red cell aplasia.The man, rituximab adisinsight https://research.birmingham.ac.uk/en/publications/rituximab-versus-azathioprine-for-maintenance-of-remission-for-pa/ Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated... for maintenance rituximab versus azathioprine https://research.birmingham.ac.uk/en/publications/tumour-necrosis-factor-inhibition-versus-rituximab-for-patients-w/ Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who... https://pubmed.ncbi.nlm.nih.gov/30661133/ Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple... Treating RRMS patients with alemtuzumab or rituximab after fingolimod withdrawal is effective and safe, without significant differences between both groups in... https://connect.mayoclinic.org/comment/862278/replies/ Replies to Can we get an update? Is it responding to treatment? Did they use Rituximab? Hope it...... View direct replies to Can we get an update? Is it responding to treatment? Did they use Rituximab? Hope it... https://adisinsight.springer.com/drugsafety/803927281?error=cookies_not_supported&code=5b5bf085-8377-4730-92ab-976575ac9595 Rituximab - AdisInsight A 54-year-old woman with nephrotic syndrome and idiopathic membranous nephropathy that later evolved into systemic lupus erythematosus with class V lupus rituximab adisinsight https://researchconnect.buffalo.edu/en/publications/population-pharmacokinetics-and-pharmacodynamics-of-carfilzomib-i/ Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab,... population pharmacokinetics pharmacodynamics carfilzomib combination https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-ibrutinib-and-rituximab-for-post-transplant-lymphoproliferative-disorder-tidal Cancer Research UK | A trial looking at ibrutinib and rituximab for post-transplant... This trial looked at adding ibrutinib to rituximab to treat post-transplant lymphoproliferative disorder. cancer research uk https://www.cancerresearchuk.org/about-cancer/treatment/drugs/methotrexate-cytarabine-thiotepa-rituximab Methotrexate, cytarabine, thiotepa and rituximab (MATRix) | Cancer Research UK MATRix is a cancer drug combination used for central nervous system lymphoma (CNS lymphoma). Find out about how you have it and possible side effects. cancer research methotrexate cytarabine rituximab matrix https://adisinsight.springer.com/drugsafety/803926017?error=cookies_not_supported&code=68eae3e1-d353-455d-a0c8-6db6e3e8b25c Rituximab - AdisInsight A 30-year-old woman with myasthenia gravis developed vitiligo and alopecia universalis during long-term treatment with rituximab. The woman received rituximab rituximab adisinsight https://adisinsight.springer.com/drugsafety/803291336?error=cookies_not_supported&code=6f689594-8d0b-4241-bc01-4970236a7c0e Immunosuppressants/rituximab - AdisInsight A retrospective multi-center study described a 50-year-old woman, who developed hepatitis B virus(HBV) reactivation during treatment with methotrexate, immunosuppressants rituximab adisinsight